Skip Navigation LinksHome > About the Journal

About the Journal

Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy.

Publication & Editorial Staff Contacts


Publication
Phil Daly
Phil.Daly@wolterskluwer.com

Production Editor
Kavi Ganeshananthan
Kavi.Ganeshananthan@wolterskluwer.com

Marketing
Jon Muir
Jon.Muir@wolterskluwer.com

Translation, Rights & Licensing
Silvia Serra
translationrights@wolterskluwer.com

LWW Business Offices
250 Waterloo Road
London SE1 8RD, UK
Phone: +44-(0)20 7981 0600
www.lww.com

International Advertising Representative
The Point of Difference
4 Chase Avenue
London SW20 8LU, UK
Phone: +44-(0)20 8542 3200
Fax: +44-(0)20 8543 3810
pointofdiff@btinternet.com

Editor-in-Chief
Mels Sluyser, PhD
The Netherlands Cancer Institute-H4
Plesmanlaan 121
1066 CX Amsterdam
The Netherlands
Phone: +31 35 52 59 943
Fax: +31 20 51 22 029
m.sluyser@planet.nl